null - FindTrial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2014-004228-23-FR

Enrollment

Registered

2015-06-19

Start date

2015-01-08

Completion date

Unknown

Last updated

2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

see below

Interventions

Product Name: Triheptanoin Product Code: UX007 Pharmaceutical Form: Oral solution INN or Proposed INN: Not available CAS Number: 620-67-7 Current Sponsor code: UX007 Other descriptive name: TRIHEPTANO

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: N/A Are the trial subjects under 18? yes Number of subjects for this age range: 10 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 10 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 10

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Main Objective: N/A;Secondary Objective: N/A;Primary end point(s): see below;Timepoint(s) of evaluation of this end point: see below	—

Secondary

Measure	Time frame
Secondary end point(s): see below;Timepoint(s) of evaluation of this end point: see below	—

Countries

France

Contacts

Public ContactGUEGUEN

Sonia

rqrc.siege@inserm.fr33144236105

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026